- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Lani Alison Outlines Questions Patients Have About Care Pathways, Treatment Guidelines
Lani M. Alison, BSN, MS, HCQ, PCMH, CCE, vice president of Clinical Affairs, Regional Cancer Care Associates, explains the questions that patients have about oncology care pathways and treatment guidelines.
Lani M. Alison, BSN, MS, HCQ, PCMH, CCE, vice president of Clinical Affairs, Regional Cancer Care Associates, explains the questions that patients have about oncology care pathways and treatment guidelines.
Transcript
What types of questions do patients ask about oncology care pathways and treatment guidelines?
They always ask, “Am I getting the low-cost treatments/ therapies because I’m on this pathway? What does pathway really mean?” So, we educate the patients that it’s an advantage for them because those pathways have been researched, are actively being studied, and are actively being used by many, so there is evidence that this is better and it also gives them a reassurance if we educate them well that these are the therapies that actually are tested already, that you don’t have to feel like you’re a guinea pig or anything like that that they would think because of the word pathway and that doesn’t really mean that because I’m getting the lowest cost I’m getting the lowest type of regimen. It’s like you’re buying a cheaper bag versus a designer bag. So, we have to be able to educate our patients that that is not so.
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
NCCN Data Find Racial, Socioeconomic Disparities in Quality of Care for Metastatic Pancreatic Cancer
April 9th 2025New data from the National Comprehensive Cancer Network (NCCN) reveal that socially vulnerable and minority patients with metastatic pancreatic cancer are less likely to receive recommended treatments and achieve longer survival.
Read More
